10.20.15
Wayland, Mass.-based Syneron Medical Ltd. (branded as Syneron Candela since 2009) has launched its Picoway Resolve internationally. The technology is a dual wavelength fractional modality for the Picoway picosecond laser. The launch of the new Resolve fractional picosecond modality, which features both 532 nm and 1064 nm wavelengths, comes less than a year after the November 2014 launch of the Picoway platform.
Picoway utilizes proprietary Picoway technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. Picoway delivers the shortest picosecond pulses and the highest peak power of any picosecond device on the market.
According to Syneron Candela, Resolve is the only picosecond device on the market to employ a holographic fractionator to deliver precisely consistent energy to the entire treatment area, which results in pristine, reproducible results. Resolve’s two wavelengths enable treatment of shallow lesions with the 532nm wavelength, while the 1064 nm wavelength is used for deeper lesions and to treat all skin types, with no downtime.
“Picoway continues to exceed expectations and delight customers,” said Amit Meridor, CEO of Syneron Candela. “We are thrilled to introduce to the market the next step in the Picoway story, Resolve, the fractional modality that uniquely includes two wavelengths. Our Picoway customers know that we have a robust road map for Picoway which includes expanded applications and new capabilities enabled by outstanding technology. It is energizing to witness the excitement that this product is experiencing in the marketplace as we introduce appealing new ways to utilize the technology to treat patients.”
“We recently began to use the novel Picoway fractional handpieces for skin rejuvenation, acne scars and wrinkles with improvement in skin tone, brightness and texture after one or two treatments,” said David Feldman, M.D., board certified dermatologist.
Picoway utilizes proprietary Picoway technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. Picoway delivers the shortest picosecond pulses and the highest peak power of any picosecond device on the market.
According to Syneron Candela, Resolve is the only picosecond device on the market to employ a holographic fractionator to deliver precisely consistent energy to the entire treatment area, which results in pristine, reproducible results. Resolve’s two wavelengths enable treatment of shallow lesions with the 532nm wavelength, while the 1064 nm wavelength is used for deeper lesions and to treat all skin types, with no downtime.
“Picoway continues to exceed expectations and delight customers,” said Amit Meridor, CEO of Syneron Candela. “We are thrilled to introduce to the market the next step in the Picoway story, Resolve, the fractional modality that uniquely includes two wavelengths. Our Picoway customers know that we have a robust road map for Picoway which includes expanded applications and new capabilities enabled by outstanding technology. It is energizing to witness the excitement that this product is experiencing in the marketplace as we introduce appealing new ways to utilize the technology to treat patients.”
“We recently began to use the novel Picoway fractional handpieces for skin rejuvenation, acne scars and wrinkles with improvement in skin tone, brightness and texture after one or two treatments,” said David Feldman, M.D., board certified dermatologist.